The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Side effects

Constipation management, with a dietitian's contribution

Solved
Solved by d.szymanski in post #5
Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is usually effective. This is worth addressing proactively rather than waiting for it to worsen.

Jump to the accepted answer →

SF
sterile_fileTL3Regular4 Nov 2025#1

Posting this under the heading it deserves: Constipation management, with a dietitian's contribution Everything below is what sits behind that.

Practical question with the units stated, because I have seen how quickly these go wrong without them.

I have a 5 mg vial of semaglutide and I am working to a 1.0 mg step. My syringes are U-100 insulin syringes, 1.0 mL barrel.

I can do the arithmetic and I have done it twice, getting the same answer both times, but I would like someone to check the reasoning rather than the number — specifically whether I have thought about the residual volume correctly, and whether the graduation I am landing on is one a person can actually read.

5 likes 9mo
SD
st.dialloTL2 Moderator11 Nov 2025#2

Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you track whether something is worsening or stable and helps your clinician understand what you are reporting.

9 likes 8mo
GV
g.valckenaereTL3Regular17 Nov 2025 · edited#3

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

29 likes 8mo
AL
a.lindqvistTL2 Moderator22 Nov 2025#4

Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears.

0 likes 8mo
DS
d.szymanskiTL3Wiki editor Solution26 Nov 2025#5
sterile_file, post #1: Posting this under the heading it deserves: Constipation management, with a dietitian's contribution Everything below is what sits behind that. Practical question with the units stated, because I have seen how quickly these go wrong without them. I have a 5 mg vial of semaglutide and I am working to a 1.0 mg step. My syringes are U-100… Go to post

Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is usually effective. This is worth addressing proactively rather than waiting for it to worsen.

12 likes in reply to #1 8mo
MI
m.ilungaTL2 Moderator30 Nov 2025#6
st.diallo, post #2: Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you track whether something is worsening or stable and helps your clinician understand what you are reporting. Go to post

Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during titration is ordinary. Persistent vomiting or vomiting of a new character later in treatment warrants contact with your clinician.

14 likes in reply to #2 8mo
K
KAnderssonTL3Regular4 Dec 2025#7

Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting those details gets better responses than reporting the symptom alone.

0 likes 8mo
ST
s.teixeiraTL2 Moderator8 Dec 2025#8

Coming back to post #6, because the follow-up matters more than the original answer.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

0 likes 8mo
PR
policy_readerTL2Regular12 Dec 2025#9

Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency.

9 likes 8mo
EA
e.adeyemiTL215 Dec 2025#10
C
CSagredoTL3Regular19 Dec 2025#11

Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound specifically. It is usually self-limiting.

0 likes 7mo
RN
r.novakTL2 Moderator22 Dec 2025#12

Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training intensity both help preserve lean mass during weight reduction.

26 likes 7mo
OA
o.abrahamsenTL3Regular26 Dec 2025#13
KAndersson, post #7: Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting those details gets better responses than reporting the symptom alone. Go to post

Worth separating two things that post #9 runs together.

Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and attenuates as the dose is held stable. At each escalation step it often resets briefly before attenuating again.

12 likes in reply to #7 7mo
KA
k.adeyemiTL2 Moderator29 Dec 2025#14
a.lindqvist, post #4: Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears. Go to post

post #13 is right about the mechanism and I think understates the practical bit.

Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid.

4 likes in reply to #4 7mo
EK
e.kjeldsenTL2Member1 Jan 2026#15

Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training intensity both help preserve lean mass during weight reduction.

0 likes 7mo
PL
p.lindqvistTL2 Moderator5 Jan 2026#16

Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound specifically. It is usually self-limiting.

0 likes 7mo
CE
crossover_entryTL3Regular8 Jan 2026 · edited#17
CSagredo, post #11: Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound specifically. It is usually self-limiting. Go to post

On post #13 — agreed on the reasoning, with one qualification.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

18 likes in reply to #11 7mo
BW
br.wikstromTL2 Moderator11 Jan 2026#18

Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency.

7 likes 7mo
MC
m.coelhoTL2 Moderator14 Jan 2026#19

I read post #17 twice before replying, because I had assumed the opposite.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

1 like 6mo
BV
b.vestergaardTL2 Moderator17 Jan 2026#20

This follows post #17 rather than contradicting it.

Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious complication. Distinguishing ordinary gastrointestinal effects from the rare severe end is a clinical judgement.

0 likes 6mo
BV
bias_varianceTL4Biostatistician20 Jan 2026#21
a.lindqvist, post #4: Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears. Go to post

This follows post #18 rather than contradicting it.

Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid.

5 likes in reply to #4 6mo
MS
m.steinerTL2 Moderator23 Jan 2026#22
policy_reader, post #9: Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency. Go to post

I read post #20 twice before replying, because I had assumed the opposite.

Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping the drug and seeking immediate evaluation is appropriate. Do not interpret this as "likely" — it is rare — but recognize the pattern if it appears.

15 likes in reply to #9 6mo
IT
impurity_tableTL3Analytical chemist26 Jan 2026#23

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

0 likes 6mo
SO
s.ostergaardTL2 Moderator29 Jan 2026#24

Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before attributing all of it to the compound. Some fatigue resolves with time; some persists.

1 like 6mo
RM
r.mcalisterTL3Regular1 Feb 2026#25

Picking up post #22: that is the part I would want checked first.

Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you track whether something is worsening or stable and helps your clinician understand what you are reporting.

9 likes 6mo
IB
i.balogunTL2 Moderator4 Feb 2026 · edited#26
k.adeyemi, post #14: post #13 is right about the mechanism and I think understates the practical bit. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid. Go to post

Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting those details gets better responses than reporting the symptom alone.

21 likes in reply to #14 6mo
B
batchlogTL3Regular7 Feb 2026#27

Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and attenuates as the dose is held stable. At each escalation step it often resets briefly before attenuating again.

0 likes 6mo
CC
c.chowdhuryTL2 Moderator9 Feb 2026#28

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

2 likes 6mo
ZO
z.onwukaTL2 Moderator12 Feb 2026#29
r.novak, post #12: Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training intensity both help preserve lean mass during weight reduction. Go to post

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

1 like in reply to #12 5mo
VS
v.sjobergTL2 Moderator15 Feb 2026#30

Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is usually effective. This is worth addressing proactively rather than waiting for it to worsen.

6 likes 5mo